Strengths and considerations
No source-reviewed explanatory claims are recorded here yet.
Can local sequence changes predict the direction and magnitude of measured molecular-trait effects?
AlphaGenome Nature 2026 supplementary comparison tables; AlphaGenome Nature 2026 supplementary methods; alphagenome: Journal full-text XML · 'Suppl Table 4 Variant performan'!A33:P33; 'Suppl Table 4 Variant performan'!A34:P34; Supplementary Methods p.30, Chromosome Splits for Variant Benchmarks; Supplementary Methods pp.36–37, Chromatin accessibility variants & bQTLs; methods: pp.36–37, Chromatin accessibility variants & bQTLs; paper: Sec10; Fig.5a–c; Supplementary Fig.9; methods: p.30, Chromosome Splits for Variant Benchmarks; paper: Fig.1e; tables: Suppl Table 4 Variant performan; evaluation index 24; sheet rows 33, 34Explanatory profile: limited source coverage · Automated source review, 2026-09-17. Review applies to the cited claims; unresolved fields are listed below. Numerical results retain their own review status.
| Property | Description and evidence |
|---|---|
| Dataset and biological context | Coronary smooth-muscle caQTL data reused from the ChromBPNet evaluation; retain this ancestry/cell-type/trait identity.AlphaGenome Nature 2026 supplementary comparison tables; AlphaGenome Nature 2026 supplementary methods; alphagenome: Journal full-text XML · 'Suppl Table 4 Variant performan'!A33:P33; 'Suppl Table 4 Variant performan'!A34:P34; Supplementary Methods p.30, Chromosome Splits for Variant Benchmarks; Supplementary Methods pp.36–37, Chromatin accessibility variants & bQTLs; methods: pp.36–37, Chromatin accessibility variants & bQTLs; paper: Sec10; Fig.5a–c; Supplementary Fig.9; methods: p.30, Chromosome Splits for Variant Benchmarks; paper: Fig.1e; tables: Suppl Table 4 Variant performan; evaluation index 24; sheet rows 33, 34 |
| Split | Zero-shot scorer development uses validation chromosomes 1,2,4,5,7,8,10,11,13,14,15,17,20,22,X; final test chromosomes are 3,6,9,12,16,18,19,21. This partitions variant evaluation labels; the distilled model’s teachers were trained on all reference-genome folds.AlphaGenome Nature 2026 supplementary comparison tables; AlphaGenome Nature 2026 supplementary methods; alphagenome: Journal full-text XML · 'Suppl Table 4 Variant performan'!A33:P33; 'Suppl Table 4 Variant performan'!A34:P34; Supplementary Methods p.30, Chromosome Splits for Variant Benchmarks; Supplementary Methods pp.36–37, Chromatin accessibility variants & bQTLs; methods: pp.36–37, Chromatin accessibility variants & bQTLs; paper: Sec10; Fig.5a–c; Supplementary Fig.9; methods: p.30, Chromosome Splits for Variant Benchmarks; paper: Fig.1e; tables: Suppl Table 4 Variant performan; evaluation index 24; sheet rows 33, 34 |
| Allowed inputs and adaptation | REF/ALT sequence and local predicted assay-signal changes. Track selection performed on validation data: AlphaGenome left-cardiac-atrium ATAC; Borzoi vascular-smooth-muscle ATAC.AlphaGenome Nature 2026 supplementary comparison tables; AlphaGenome Nature 2026 supplementary methods; alphagenome: Journal full-text XML · 'Suppl Table 4 Variant performan'!A33:P33; 'Suppl Table 4 Variant performan'!A34:P34; Supplementary Methods p.30, Chromosome Splits for Variant Benchmarks; Supplementary Methods pp.36–37, Chromatin accessibility variants & bQTLs; methods: pp.36–37, Chromatin accessibility variants & bQTLs; paper: Sec10; Fig.5a–c; Supplementary Fig.9; methods: p.30, Chromosome Splits for Variant Benchmarks; paper: Fig.1e; tables: Suppl Table 4 Variant performan; evaluation index 24; sheet rows 33, 34 |
| Metrics as reported | pearsonrAlphaGenome Nature 2026 supplementary comparison tables; AlphaGenome Nature 2026 supplementary methods; alphagenome: Journal full-text XML · 'Suppl Table 4 Variant performan'!A33:P33; 'Suppl Table 4 Variant performan'!A34:P34; Supplementary Methods p.30, Chromosome Splits for Variant Benchmarks; Supplementary Methods pp.36–37, Chromatin accessibility variants & bQTLs; methods: pp.36–37, Chromatin accessibility variants & bQTLs; paper: Sec10; Fig.5a–c; Supplementary Fig.9; methods: p.30, Chromosome Splits for Variant Benchmarks; paper: Fig.1e; tables: Suppl Table 4 Variant performan; evaluation index 24; sheet rows 33, 34 |
| Aggregation | Pearson correlation against reported effect sizes of the causal/significant QTL set.AlphaGenome Nature 2026 supplementary comparison tables; AlphaGenome Nature 2026 supplementary methods; alphagenome: Journal full-text XML · 'Suppl Table 4 Variant performan'!A33:P33; 'Suppl Table 4 Variant performan'!A34:P34; Supplementary Methods p.30, Chromosome Splits for Variant Benchmarks; Supplementary Methods pp.36–37, Chromatin accessibility variants & bQTLs; methods: pp.36–37, Chromatin accessibility variants & bQTLs; paper: Sec10; Fig.5a–c; Supplementary Fig.9; methods: p.30, Chromosome Splits for Variant Benchmarks; paper: Fig.1e; tables: Suppl Table 4 Variant performan; evaluation index 24; sheet rows 33, 34 |
| Uncertainty | Not reported for these summary-table scores. · Not reported in inspected sourcesAlphaGenome Nature 2026 supplementary comparison tables; AlphaGenome Nature 2026 supplementary methods; alphagenome: Journal full-text XML · 'Suppl Table 4 Variant performan'!A33:P33; 'Suppl Table 4 Variant performan'!A34:P34; Supplementary Methods p.30, Chromosome Splits for Variant Benchmarks; Supplementary Methods pp.36–37, Chromatin accessibility variants & bQTLs; methods: pp.36–37, Chromatin accessibility variants & bQTLs; paper: Sec10; Fig.5a–c; Supplementary Fig.9; methods: p.30, Chromosome Splits for Variant Benchmarks; paper: Fig.1e; tables: Suppl Table 4 Variant performan; evaluation index 24; sheet rows 33, 34 |
| Entity type | protocol |
| Organisms | Not extracted or verified for this record. |
| Assays | Not extracted or verified for this record. |
| Baselines | Not extracted or verified for this record. |
Conceptual summary of the cited procedure; model-specific conditions are given below.
Can local sequence changes predict the direction and magnitude of measured molecular-trait effects?
AlphaGenome Nature 2026 supplementary comparison tables; AlphaGenome Nature 2026 supplementary methods; alphagenome: Journal full-text XML · 'Suppl Table 4 Variant performan'!A33:P33; 'Suppl Table 4 Variant performan'!A34:P34; Supplementary Methods p.30, Chromosome Splits for Variant Benchmarks; Supplementary Methods pp.36–37, Chromatin accessibility variants & bQTLs; methods: pp.36–37, Chromatin accessibility variants & bQTLs; paper: Sec10; Fig.5a–c; Supplementary Fig.9; methods: p.30, Chromosome Splits for Variant Benchmarks; paper: Fig.1e; tables: Suppl Table 4 Variant performan; evaluation index 24; sheet rows 33, 34Use the source’s local log-fold-change scorer, select the task-specific cell/assay tracks and compare against the source-provided QTL labels or measured effects.
AlphaGenome Nature 2026 supplementary comparison tables; AlphaGenome Nature 2026 supplementary methods; alphagenome: Journal full-text XML · 'Suppl Table 4 Variant performan'!A33:P33; 'Suppl Table 4 Variant performan'!A34:P34; Supplementary Methods p.30, Chromosome Splits for Variant Benchmarks; Supplementary Methods pp.36–37, Chromatin accessibility variants & bQTLs; methods: pp.36–37, Chromatin accessibility variants & bQTLs; paper: Sec10; Fig.5a–c; Supplementary Fig.9; methods: p.30, Chromosome Splits for Variant Benchmarks; paper: Fig.1e; tables: Suppl Table 4 Variant performan; evaluation index 24; sheet rows 33, 34Release 2026-09-17-a757f4af4277 · 3 evaluations · 3 metric rows. Different protocols are not a single leaderboard.
| Metric and finding | Coverage and uncertainty | Evidence |
|---|---|---|
| chrombpnet (paper Table 4): Coronary smooth-muscle caQTL effect-size prediction Model: chrombpnet (paper Table 4) · Benchmark: Coronary smooth-muscle caQTL effect-size prediction (AlphaGenome paper) · Dataset: Coronary smooth-muscle caQTL effect-size prediction: evaluated data subset Use the source’s local log-fold-change scorer, select the task-specific cell/assay tracks and compare against the source-provided QTL labels or measured effects. Author-reported evaluation · Evaluation metadata: needs review | ||
| 0.658407 pearsonr Unit: correlation · Direction: higher Aggregation: Pearson correlation against reported effect sizes of the causal/significant QTL set. | Uncertainty: unreported Scored: Not reported · Eligible: Not reported | source checkedAlphaGenome Nature 2026 supplementary comparison tables · 'Suppl Table 4 Variant performan'!L34 Source checking is not independent reproduction. |
| AlphaGenome distilled all-fold student: Coronary smooth-muscle caQTL effect-size prediction Model: AlphaGenome distilled all-fold student · Benchmark: Coronary smooth-muscle caQTL effect-size prediction (AlphaGenome paper) · Dataset: Coronary smooth-muscle caQTL effect-size prediction: evaluated data subset Use the source’s local log-fold-change scorer, select the task-specific cell/assay tracks and compare against the source-provided QTL labels or measured effects. Author-reported evaluation · Evaluation metadata: needs review | ||
| 0.69 pearsonr Unit: correlation · Direction: higher Aggregation: Pearson correlation against reported effect sizes of the causal/significant QTL set. | Uncertainty: unreported Scored: Not reported · Eligible: Not reported | source checkedAlphaGenome Nature 2026 supplementary comparison tables · 'Suppl Table 4 Variant performan'!M33; 'Suppl Table 4 Variant performan'!M34 Source checking is not independent reproduction. |
| borzoi-ensemble (paper Table 4): Coronary smooth-muscle caQTL effect-size prediction Model: borzoi-ensemble (paper Table 4) · Benchmark: Coronary smooth-muscle caQTL effect-size prediction (AlphaGenome paper) · Dataset: Coronary smooth-muscle caQTL effect-size prediction: evaluated data subset Use the source’s local log-fold-change scorer, select the task-specific cell/assay tracks and compare against the source-provided QTL labels or measured effects. Author-reported evaluation · Evaluation metadata: needs review | ||
| 0.63039 pearsonr Unit: correlation · Direction: higher Aggregation: Pearson correlation against reported effect sizes of the causal/significant QTL set. | Uncertainty: unreported Scored: Not reported · Eligible: Not reported | source checkedAlphaGenome Nature 2026 supplementary comparison tables · 'Suppl Table 4 Variant performan'!L33 Source checking is not independent reproduction. |
No source-reviewed explanatory claims are recorded here yet.
Primary-source transcription and separate automated source review. No human sign-off or independent experimental reproduction.
Stable record: alphagenome-2026-t4-protocol-24Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
42 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
| Diagram caption Conceptual summary of the cited procedure; model-specific conditions are given below. Individual claims | alphagenome: Journal full-text XML 'Suppl Table 4 Variant performan'!A33:P33; 'Suppl Table 4 Variant performan'!A34:P34; Supplementary Methods p.30, Chromosome Splits for Variant Benchmarks; Supplementary Methods pp.36–37, Chromatin accessibility variants & bQTLs; methods: pp.36–37, Chromatin accessibility variants & bQTLs; paper: Sec10; Fig.5a–c; Supplementary Fig.9; methods: p.30, Chromosome Splits for Variant Benchmarks; paper: Fig.1e; tables: Suppl Table 4 Variant performan; evaluation index 24; sheet rows 33, 34 Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: Retrieved page snapshot; no immutable publisher revision supplied | source checked automated source review · 2026-09-17 Audit detailsPrimary-source transcription and separate automated source review. No human sign-off or independent experimental reproduction. Field: Source artifact SHA-256: Hash scope: SHA-256 of retrieved original artifact bytes Format: original_artifact |
| Diagram caption Conceptual summary of the cited procedure; model-specific conditions are given below. Individual claims | AlphaGenome Nature 2026 supplementary methods 'Suppl Table 4 Variant performan'!A33:P33; 'Suppl Table 4 Variant performan'!A34:P34; Supplementary Methods p.30, Chromosome Splits for Variant Benchmarks; Supplementary Methods pp.36–37, Chromatin accessibility variants & bQTLs; methods: pp.36–37, Chromatin accessibility variants & bQTLs; paper: Sec10; Fig.5a–c; Supplementary Fig.9; methods: p.30, Chromosome Splits for Variant Benchmarks; paper: Fig.1e; tables: Suppl Table 4 Variant performan; evaluation index 24; sheet rows 33, 34 Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: Supplement to Nature version of record, 28 January 2026; content hash pinned | source checked automated source review · 2026-09-17 Audit detailsPrimary-source transcription and separate automated source review. No human sign-off or independent experimental reproduction. Field: Source artifact SHA-256: Hash scope: SHA-256 of exact publisher PDF bytes Format: original_pdf |
| Diagram caption Conceptual summary of the cited procedure; model-specific conditions are given below. Individual claims | AlphaGenome Nature 2026 supplementary comparison tables 'Suppl Table 4 Variant performan'!A33:P33; 'Suppl Table 4 Variant performan'!A34:P34; Supplementary Methods p.30, Chromosome Splits for Variant Benchmarks; Supplementary Methods pp.36–37, Chromatin accessibility variants & bQTLs; methods: pp.36–37, Chromatin accessibility variants & bQTLs; paper: Sec10; Fig.5a–c; Supplementary Fig.9; methods: p.30, Chromosome Splits for Variant Benchmarks; paper: Fig.1e; tables: Suppl Table 4 Variant performan; evaluation index 24; sheet rows 33, 34 Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: Nature version of record, 28 January 2026 | source checked automated source review · 2026-09-17 Audit detailsPrimary-source transcription and separate automated source review. No human sign-off or independent experimental reproduction. Field: Source artifact SHA-256: Hash scope: SHA-256 of exact retrieved original artifact bytes Format: xlsx |
| Diagram steps ["Select ancestry/cell-specific QTL test set","Match the reported assay tracks","Score local REF/ALT signal change","Correlate with measured effects"] Individual claims | alphagenome: Journal full-text XML 'Suppl Table 4 Variant performan'!A33:P33; 'Suppl Table 4 Variant performan'!A34:P34; Supplementary Methods p.30, Chromosome Splits for Variant Benchmarks; Supplementary Methods pp.36–37, Chromatin accessibility variants & bQTLs; methods: pp.36–37, Chromatin accessibility variants & bQTLs; paper: Sec10; Fig.5a–c; Supplementary Fig.9; methods: p.30, Chromosome Splits for Variant Benchmarks; paper: Fig.1e; tables: Suppl Table 4 Variant performan; evaluation index 24; sheet rows 33, 34 Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: Retrieved page snapshot; no immutable publisher revision supplied | source checked automated source review · 2026-09-17 Audit detailsPrimary-source transcription and separate automated source review. No human sign-off or independent experimental reproduction. Field: Source artifact SHA-256: Hash scope: SHA-256 of retrieved original artifact bytes Format: original_artifact |
| Diagram steps ["Select ancestry/cell-specific QTL test set","Match the reported assay tracks","Score local REF/ALT signal change","Correlate with measured effects"] Individual claims | AlphaGenome Nature 2026 supplementary methods 'Suppl Table 4 Variant performan'!A33:P33; 'Suppl Table 4 Variant performan'!A34:P34; Supplementary Methods p.30, Chromosome Splits for Variant Benchmarks; Supplementary Methods pp.36–37, Chromatin accessibility variants & bQTLs; methods: pp.36–37, Chromatin accessibility variants & bQTLs; paper: Sec10; Fig.5a–c; Supplementary Fig.9; methods: p.30, Chromosome Splits for Variant Benchmarks; paper: Fig.1e; tables: Suppl Table 4 Variant performan; evaluation index 24; sheet rows 33, 34 Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: Supplement to Nature version of record, 28 January 2026; content hash pinned | source checked automated source review · 2026-09-17 Audit detailsPrimary-source transcription and separate automated source review. No human sign-off or independent experimental reproduction. Field: Source artifact SHA-256: Hash scope: SHA-256 of exact publisher PDF bytes Format: original_pdf |
| Diagram steps ["Select ancestry/cell-specific QTL test set","Match the reported assay tracks","Score local REF/ALT signal change","Correlate with measured effects"] Individual claims | AlphaGenome Nature 2026 supplementary comparison tables 'Suppl Table 4 Variant performan'!A33:P33; 'Suppl Table 4 Variant performan'!A34:P34; Supplementary Methods p.30, Chromosome Splits for Variant Benchmarks; Supplementary Methods pp.36–37, Chromatin accessibility variants & bQTLs; methods: pp.36–37, Chromatin accessibility variants & bQTLs; paper: Sec10; Fig.5a–c; Supplementary Fig.9; methods: p.30, Chromosome Splits for Variant Benchmarks; paper: Fig.1e; tables: Suppl Table 4 Variant performan; evaluation index 24; sheet rows 33, 34 Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: Nature version of record, 28 January 2026 | source checked automated source review · 2026-09-17 Audit detailsPrimary-source transcription and separate automated source review. No human sign-off or independent experimental reproduction. Field: Source artifact SHA-256: Hash scope: SHA-256 of exact retrieved original artifact bytes Format: xlsx |
| Diagram title Coronary smooth-muscle caQTL effect-size prediction: evaluation procedure Individual claims | alphagenome: Journal full-text XML 'Suppl Table 4 Variant performan'!A33:P33; 'Suppl Table 4 Variant performan'!A34:P34; Supplementary Methods p.30, Chromosome Splits for Variant Benchmarks; Supplementary Methods pp.36–37, Chromatin accessibility variants & bQTLs; methods: pp.36–37, Chromatin accessibility variants & bQTLs; paper: Sec10; Fig.5a–c; Supplementary Fig.9; methods: p.30, Chromosome Splits for Variant Benchmarks; paper: Fig.1e; tables: Suppl Table 4 Variant performan; evaluation index 24; sheet rows 33, 34 Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: Retrieved page snapshot; no immutable publisher revision supplied | source checked automated source review · 2026-09-17 Audit detailsPrimary-source transcription and separate automated source review. No human sign-off or independent experimental reproduction. Field: Source artifact SHA-256: Hash scope: SHA-256 of retrieved original artifact bytes Format: original_artifact |
| Diagram title Coronary smooth-muscle caQTL effect-size prediction: evaluation procedure Individual claims | AlphaGenome Nature 2026 supplementary methods 'Suppl Table 4 Variant performan'!A33:P33; 'Suppl Table 4 Variant performan'!A34:P34; Supplementary Methods p.30, Chromosome Splits for Variant Benchmarks; Supplementary Methods pp.36–37, Chromatin accessibility variants & bQTLs; methods: pp.36–37, Chromatin accessibility variants & bQTLs; paper: Sec10; Fig.5a–c; Supplementary Fig.9; methods: p.30, Chromosome Splits for Variant Benchmarks; paper: Fig.1e; tables: Suppl Table 4 Variant performan; evaluation index 24; sheet rows 33, 34 Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: Supplement to Nature version of record, 28 January 2026; content hash pinned | source checked automated source review · 2026-09-17 Audit detailsPrimary-source transcription and separate automated source review. No human sign-off or independent experimental reproduction. Field: Source artifact SHA-256: Hash scope: SHA-256 of exact publisher PDF bytes Format: original_pdf |
| Diagram title Coronary smooth-muscle caQTL effect-size prediction: evaluation procedure Individual claims | AlphaGenome Nature 2026 supplementary comparison tables 'Suppl Table 4 Variant performan'!A33:P33; 'Suppl Table 4 Variant performan'!A34:P34; Supplementary Methods p.30, Chromosome Splits for Variant Benchmarks; Supplementary Methods pp.36–37, Chromatin accessibility variants & bQTLs; methods: pp.36–37, Chromatin accessibility variants & bQTLs; paper: Sec10; Fig.5a–c; Supplementary Fig.9; methods: p.30, Chromosome Splits for Variant Benchmarks; paper: Fig.1e; tables: Suppl Table 4 Variant performan; evaluation index 24; sheet rows 33, 34 Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: Nature version of record, 28 January 2026 | source checked automated source review · 2026-09-17 Audit detailsPrimary-source transcription and separate automated source review. No human sign-off or independent experimental reproduction. Field: Source artifact SHA-256: Hash scope: SHA-256 of exact retrieved original artifact bytes Format: xlsx |
| Dataset and biological context Coronary smooth-muscle caQTL data reused from the ChromBPNet evaluation; retain this ancestry/cell-type/trait identity. Individual claims | alphagenome: Journal full-text XML 'Suppl Table 4 Variant performan'!A33:P33; 'Suppl Table 4 Variant performan'!A34:P34; Supplementary Methods p.30, Chromosome Splits for Variant Benchmarks; Supplementary Methods pp.36–37, Chromatin accessibility variants & bQTLs; methods: pp.36–37, Chromatin accessibility variants & bQTLs; paper: Sec10; Fig.5a–c; Supplementary Fig.9; methods: p.30, Chromosome Splits for Variant Benchmarks; paper: Fig.1e; tables: Suppl Table 4 Variant performan; evaluation index 24; sheet rows 33, 34 Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: Retrieved page snapshot; no immutable publisher revision supplied | source checked automated source review · 2026-09-17 Audit detailsPrimary-source transcription and separate automated source review. No human sign-off or independent experimental reproduction. Field: Source artifact SHA-256: Hash scope: SHA-256 of retrieved original artifact bytes Format: original_artifact |
Release 2026-09-17-a757f4af4277 · Record review: needs review
Stable ID: alphagenome-2026-t4-protocol-24